BioSpace News Archive

Pharm Country

CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior

Fusion oncogenes, such as RET- and NTRK- gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk of metastases.

January 31, 2022
·
5 min read
BioMidwest

iBIO increases support for hands-on STEM with New Phase of its STEM Kit Program

Abbott enables distribution of twice the number of STEM kits to support STEM learning for all fifth grade students in Des Plaines Community Consolidated School District 62.

January 31, 2022
·
4 min read
OSE Immunotherapeutics Announces Acceptance of the US Investigational New Drug (IND) Application Obtained by Veloxis Pharmaceuticals, Inc., its Partner in Transplantation, for CD28 Antagonist VEL-101/FR104

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced acceptance of the IND obtained by Veloxis Pharmaceuticals, Inc. from the Food & Drug Administration (FDA) for a clinical trial with VEL-101/FR104.

January 31, 2022
·
7 min read
Business

Privia Health to Report Fourth Quarter 2021 Results on Friday, March 25

Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2021 before market open on Friday, March 25, 2022.

January 31, 2022
·
1 min read
Business

Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer

Lyell Immunopharma, Inc. today announced the appointment of Gary Lee, Ph.D., as Chief Scientific Officer.

January 31, 2022
·
5 min read
Business

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately.

January 31, 2022
·
7 min read
Business

Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors

Tenax Therapeutics, Inc. announced today that Tenax Therapeutics appointed Robyn Hunter to its Board of Directors, effective January 28, 2022.

January 31, 2022
·
6 min read
Business

Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors

Checkmate Pharmaceuticals, Inc. today announced the addition of Jon Wigginton, M.D. to its Board of Directors (“Board”).

January 31, 2022
·
6 min read
Biotech Beach

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jan 31, 2022

Cardiff Oncology, Inc. announced that on January 31, 2022, non-qualified stock option awards to purchase an aggregate of 55,008 shares of its common stock were granted to one new employee.

January 31, 2022
·
2 min read
Skin Diseases Treatment Market: Increasing awareness about skin disorders to drive the market

The dermatology industry, on the whole, has been undergoing several changes over the past decade on account of the rising prevalence of skin diseases and the development of innovative therapies to combat them.

January 31, 2022
·
6 min read